Understanding and Caring for People with Inherited Leukodystrophies Diagnosis, Treatment, and Long-Term Outcomes Study

What this Trial Is About

Researchers are studying leukodystrophies, inherited disorders affecting the brains white matter, which impact about 1 in 7,500 children and have a high mortality rate over 30%. These conditions often cause serious complications like epilepsy, developmental decline, and intellectual disabilities. The study aims to improve diagnosis, care, and understanding of patient outcomes by collecting clinical histories and monitoring disease progression. This observational study is conducted through the Western Leukodystrophy Project at the University of Utah and Primary Childrens Hospital, specialized centers for leukodystrophy care. Participants receive diagnosis support, treatment suggestions, and care guideline implementation. The study tracks patient health and disease evolution over time without testing new treatments. Participants are followed for up to 20 years, with yearly check-ins to monitor complications such as spasticity, respiratory and bulbar issues, hypotonia, cerebellar and language problems, and hospitalizations. Brain MRIs are done at enrollment and repeated approximately every five years. Clinical and diagnostic testing occurs at baseline and every three years. The study measures morbidity as the primary outcome, helping researchers understand long-term effects and responses to interventions like bone marrow transplant.

Natural History, Diagnosis, and Outcomes for Leukodystrophies